Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R

por Schollhammer, Romain, Quintyn Ranty, Marie-Laure, de Clermont Gallerande, Henri, Cavelier, Florine, Valverde, Ibai E., Vimont, Delphine, Hindié, Elif, Morgat, Clément
Publicado 2023

Comparison of the radiolabeled PSMA-inhibitor (111)In-PSMA-617 and the radiolabeled GRP-R antagonist (111)In-RM2 in primary prostate cancer samples

por Schollhammer, Romain, De Clermont Gallerande, Henri, Yacoub, Mokrane, Quintyn Ranty, Marie-Laure, Barthe, Nicole, Vimont, Delphine, Hindié, Elif, Fernandez, Philippe, Morgat, Clément
Publicado 2019